Myasthenia gravis (MG) is an antigen-specific autoimmune disease caused by antibodies against acetylcholine receptors (AChRj at the post-synaptic membrane of the neuromuscular junction. Clinical and immunological data imply the involvement of AChR-specific T lymphocytes as helper cells for autoantib
Antigen-specific T-cell activation in hyperplastic thymus in myasthenia gravis
โ Scribed by Kimiaki Utsugisawa; Yuriko Nagane; Shigeaki Suzuki; Ryushi Kondoh
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 118 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Discussion This study shows that replacing one anticonvulsant drug with another is beneficial for nearly 1 in 3 patients (18 of 59; 31%) with generalized tonic-clonic or partial seizures in whom a previous single-drug therapy up to individual tolerance has failed. In addition, side effects disa
## Antigen-specific therapy of experimental myasthenia gravis with acetylcholine receptor-gelonin conjugates in viva* Rats suffering from experimental autoimmune myasthenia gravis (EAMG) induced by previous immunization with foreign acetylcholine receptor (AChR) were treated with AChR-toxin conjug